Eliminating cost‐sharing requirements for colon cancer screening in Medicare
Authors:
Open Access
Abstract
Medicare beneficiaries do not have to pay for screening colonoscopies but must pay coinsurance if a polyp is removed via polypectomy. Likewise, beneficiaries do not have to pay for fecal occult blood tests but are liable for cost‐sharing for diagnostic colonoscopies after a positive test. Legislative and regulatory requirements related to colorectal cancer screening are described, and on the basis of Medicare claims, it is estimated that Medicare spending would increase by $48 million annually if Medicare were to waive cost‐sharing requirements for these services. The economic impact on Medicare if beneficiaries were not responsible for any cost‐sharing requirements related to colorectal cancer screening services is described. Cancer 2014;120:3850–3852. © 2014 American Cancer Society.Keywords
This publication has 8 references indexed in Scilit:
- Navigating the Murky Waters of Colorectal Cancer Screening and Health ReformAmerican Journal of Public Health, 2014
- Modestly Increased Use of Colonoscopy When Copayments Are WaivedClinical Gastroenterology and Hepatology, 2012
- Cancer screening - United States, 2010.2012
- Anesthesiologist Involvement in Screening Colonoscopy: Temporal Trends and Cost Implications in the Medicare PopulationClinical Gastroenterology and Hepatology, 2012
- Overuse of Screening Colonoscopy in the Medicare PopulationArchives of internal medicine (1960), 2011
- Effect of Rising Chemotherapy Costs on the Cost Savings of Colorectal Cancer ScreeningJNCI: Journal of the National Cancer Institute, 2009
- The impact of detection and treatment on lifetime medical costs for patients with precancerous polyps and colorectal cancerHealth Economics, 2009
- Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2008